Neuroprotection by ulinastatin in experimental autoimmune encephalomyelitis

Neurochemical Research

Volumn 36, Issue 11, 2011, Pages 1969-1977

  Shu, Yaqing ^a   Yang, Yu ^a   Qiu, Wei ^a   Lu, Zhengqi ^a   Li, Ying ^a   Bao, Jian ^a   Feng, Ming ^b   Hu, Xueqiang ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Experimental autoimmune encephalomyelitis; Neuroprotection; Ulinastatin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; PROTEIN P75; SODIUM CHLORIDE; ULINASTATIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMYELINATION; DRUG EFFICACY; DRUG MECHANISM; FEMALE; MOUSE; MYELIN SHEATH; MYELINATION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEMYELINATING DISEASES; DOWN-REGULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MYELIN SHEATH; NERVE GROWTH FACTOR; NERVE REGENERATION; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIA; RECEPTORS, NERVE GROWTH FACTOR;

MUS;

EID: 80055021848     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0520-4     Document Type: Article

References (40)

1. A Kutzelnigg CF Lucchinetti C Stadelmann W Bruck H Rauschka M Bergmann M Schmidbauer JE Parisi H Lassmann 2005 Cortical demyelination and diffuse white matter injury in multiple sclerosis Brain 128 2705 2712 16230320 10.1093/brain/awh641 (Pubitemid 41552953)
2. C Lucchinetti W Bruck J Parisi B Scheithauer M Rodriguez H Lassmann 2000 Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination Ann Neurol 47 707 717 10852536 10.1002/1531-8249(200006)47: 6<707::AID-ANA3>3.0.CO;2-Q 1:STN:280:DC%2BD3czgvFektA%3D%3D (Pubitemid 30390191)
3. C Bjartmar JR Wujek BD Trapp 2003 Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease J Neurol Sci 206 165 171 12559505 10.1016/S0022-510X(02)00069-2 1:STN:280: DC%2BD3s%2FltVartw%3D%3D (Pubitemid 36143722)
4. C Cudrici T Niculescu F Niculescu ML Shin H Rus 2006 Oligodendrocyte cell death in pathogenesis of multiple sclerosis: protection of oligodendrocytes from apoptosis by complement J Rehabil Res Dev 43 123 132 16847778 10.1682/JRRD.2004.08.0111 (Pubitemid 43938753)
5. S Hisahara T Araki F Sugiyama K Yagami M Suzuki K Abe K Yamamura J Miyazaki T Momoi T Saruta CC Bernard H Okano M Miura 2000 Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination EMBO J 19 341 348 10654933 10.1093/emboj/19.3.341 1:CAS:528:DC%2BD3cXhtVShu7k%3D (Pubitemid 30072604)
6. V Skihar C Silva A Chojnacki A Doring WB Stallcup S Weiss VW Yong 2009 Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate Proc Natl Acad Sci USA 106 17992 17997 19815532 10.1073/pnas.0909607106 1:CAS:528:DC%2BD1MXhtl2qsbnN
7. CC Chen SS Wang FY Lee 2007 Action of antiproteases on the inflammatory response in acute pancreatitis JOP 8 488 494 17625305
8. H Abe N Sugino T Matsuda T Kanamaru S Oyanagi H Mori 1996 Effect of ulinastatin on delayed neuronal death in the gerbil hippocampus Masui 45 38 43 8865723 1:STN:280:DyaK2s%2FhvFWjug%3D%3D (Pubitemid 26051087)
9. T Yano S Anraku R Nakayama K Ushijima 2003 Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats Anesthesiology 98 465 473 12552207 10.1097/00000542-200302000-00028 1:CAS:528:DC%2BD3sXmsFCksw%3D%3D (Pubitemid 36592816)
10. Y Koga M Fujita R Tsuruta Y Koda T Nakahara T Yagi T Aoki C Kobayashi T Izumi S Kasaoka M Yuasa T Maekawa 2010 Urinary trypsin inhibitor suppresses excessive superoxide anion radical generation in blood, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia/reperfusion rats Neurol Res 32 925 932 20223106 10.1179/016164110X12645013515133 1:CAS:528:DC%2BC3cXhsVCru73O
11. M Tamatani S Ogawa G Nunez M Tohyama 1998 Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide Cell Death Differ 5 911 919 10203697 10.1038/sj.cdd.4400439 1:CAS:528: DyaK1cXntFOht7o%3D (Pubitemid 28484402)
12. P Villoslada SL Hauser I Bartke J Unger N Heald D Rosenberg SW Cheung WC Mobley S Fisher CP Genain 2000 Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system J Exp Med 191 1799 1806 10811872 10.1084/jem.191.10.1799 1:CAS:528:DC%2BD3cXjtlKgu7g%3D (Pubitemid 30331576)
13. A Flugel K Matsumuro H Neumann WE Klinkert R Birnbacher H Lassmann U Otten H Wekerle 2001 Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: inhibition of monocyte transendothelial migration Eur J Immunol 31 11 22 11169433 10.1002/1521- 4141(200101)31:1<11::AID-IMMU11>3.0.CO;2-G 1:CAS:528:DC%2BD3MXhtVGrsrs%3D (Pubitemid 32095993)
14. HH Althaus S Kloppner T Schmidt-Schultz P Schwartz 1992 Nerve growth factor induces proliferation and enhances fiber regeneration in oligodendrocytes isolated from adult pig brain Neurosci Lett 135 219 223 1625798 10.1016/0304-3940(92)90440-I 1:CAS:528:DyaK38Xht1Wrtro%3D
15. DM McTigue PJ Horner BT Stokes FH Gage 1998 Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord J Neurosci 18 5354 5365 9651218 1:CAS:528:DyaK1cXksFart78%3D (Pubitemid 28311952)
16. RI Cohen R Marmur WT Norton MF Mehler JA Kessler 1996 Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes J Neurosci 16 6433 6442 8815922 1:CAS:528:DyaK28Xnt1Orurw%3D (Pubitemid 26337367)
17. R Lee P Kermani KK Teng BL Hempstead 2001 Regulation of cell survival by secreted proneurotrophins Science 294 1945 1948 11729324 10.1126/science.1065057 1:CAS:528:DC%2BD3MXovFWqsb4%3D (Pubitemid 33101595)
18. MS Beattie AW Harrington R Lee JY Kim SL Boyce FM Longo JC Bresnahan BL Hempstead SO Yoon 2002 ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury Neuron 36 375 386 12408842 10.1016/S0896-6273(02) 01005-X 1:CAS:528:DC%2BD38XosV2ht7Y%3D (Pubitemid 35284727)
19. EJ Coulson K Reid SS Murray SS Cheema PF Bartlett 2000 Role of neurotrophin receptor p75NTR in mediating neuronal cell death following injury Clin Exp Pharmacol Physiol 27 537 541 10874514 10.1046/j.1440-1681.2000.03295.x 1:CAS:528:DC%2BD3cXkt12lsLs%3D (Pubitemid 30418002)
20. J Zhang C Brodie Y Li X Zheng C Roberts M Lu Q Gao J Borneman S Savant-Bhonsale SB Elias M Chopp 2009 Bone marrow stromal cell therapy reduces proNGF and p75 expression in mice with experimental autoimmune encephalomyelitis J Neurol Sci 279 30 38 19193386 10.1016/j.jns.2008.12.033 1:CAS:528: DC%2BD1MXisFGqsLo%3D
21. X Chen R Pi Y Zou M Liu X Ma Y Jiang X Mao X Hu 2010 Attenuation of experimental autoimmune encephalomyelitis in C57 BL/6 mice by osthole, a natural coumarin Eur J Pharmacol 629 40 46 20006598 10.1016/j.ejphar.2009.12.008 1:CAS:528:DC%2BC3cXhtVGqu7o%3D
22. S Kuerten DA Kostova-Bales LP Frenzel JT Tigno M Tary-Lehmann DN Angelov PV Lehmann 2007 MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum J Neuroimmunol 189 31 40 17655940 10.1016/j.jneuroim.2007.06.016 1:CAS:528:DC%2BD2sXhtVWitL%2FF (Pubitemid 47379424)
23. T Morimoto T Sasaki K Takakura 1992 Effect of ulinastatin on postischemic brain edema in cats No To Shinkei 44 337 341 1633031 1:CAS:528: DyaK38Xls1elurs%3D
24. M Munakata R Kato H Yokoyama K Haginoya Y Tanaka J Kayaba T Kato R Takayanagi H Endo R Hasegawa Y Ejima K Hoshi K Iinuma 2000 Combined therapy with hypothermia and anticytokine agents in influenza A encephalopathy Brain Dev 22 373 377 11042419 10.1016/S0387-7604(00)00169-8 1:STN:280: DC%2BD3M%2FmtFensg%3D%3D
25. DU HG LC Yin M He GJ Zhang Y Tian C Wang DU GA 2005 Application of ulinastatin in severe craniocerebral injuries Chin J Traumatol 8 236 239 (Pubitemid 41335113)
26. WM Cowan 2001 Viktor Hamburger and Rita Levi-Montalcini: the path to the discovery of nerve growth factor Annu Rev Neurosci 24 551 600 11283321 10.1146/annurev.neuro.24.1.551 1:CAS:528:DC%2BD3MXls1Shs7g%3D (Pubitemid 32695239)
27. M Sugiki H Sumi M Maruyama E Yoshida H Mihara 1989 Clearance and distribution of acid-stable trypsin inhibitor (ASTI) Enzyme 42 31 38 2776713 1:CAS:528:DyaL1MXltFaltL0%3D (Pubitemid 19175887)
28. BM Keegan JH Noseworthy 2002 Multiple sclerosis Annu Rev Med 53 285 302 11818475 10.1146/annurev.med.53.082901.103909 1:CAS:528:DC%2BD38Xitl2mtrk%3D (Pubitemid 34182821)
29. N Weiss F Miller S Cazaubon PO Couraud 2009 The blood-brain barrier in brain homeostasis and neurological diseases Biochim Biophys Acta 1788 842 857 19061857 10.1016/j.bbamem.2008.10.022 1:CAS:528:DC%2BD1MXktFahur0%3D
30. X Ma Y Jiang A Wu X Chen R Pi M Liu Y Liu 2010 Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice PLoS One 5 e13489 20976070 10.1371/journal.pone.0013489
31. H Lassmann B Schwerer K Kitz M Egghart H Bernheimer 1983 Pathogenetic aspects of demyelinating lesions in chronic relapsing experimental allergic encephalomyelitis: possible interaction of cellular and humoral immune mechanisms Prog Brain Res 59 305 315 6198681 10.1016/S0079-6123(08)63875-3 1:STN:280:DyaL2c7itVWgsg%3D%3D
32. YJ Wu Q Ling XH Zhou Y Wang HY Xie JR Yu SS Zheng 2009 Urinary trypsin inhibitor attenuates hepatic ischemia-reperfusion injury by reducing nuclear factor-kappa B activation Hepatobiliary Pancreat Dis Int 8 53 58 19208516 1:CAS:528:DC%2BD1MXjtFGgtL8%3D
33. XK Li AF Matin H Suzuki T Uno T Yamaguchi Y Harada 1993 Effect of protease inhibitor on ischemia/reperfusion injury of the rat liver Transplantation 56 1331 1336 8278998 10.1097/00007890-199312000-00008 1:CAS:528:DyaK2cXivFGlu7Y%3D (Pubitemid 24018779)
34. CC Chen ZM Liu HH Wang W He Y Wang WD Wu 2004 Effects of ulinastatin on renal ischemia-reperfusion injury in rats Acta Pharmacol Sin 25 1334 1340 15456536 1:CAS:528:DC%2BD2cXovVeqsbg%3D (Pubitemid 39361806)
35. B Ren H Wu J Zhu D Li Y Shen R Ying G Dong H Jing 2006 Ulinastatin attenuates lung ischemia-reperfusion injury in rats by inhibiting tumor necrosis factor alpha Transplant Proc 38 2777 2779 17112827 10.1016/j.transproceed.2006. 08.166 1:CAS:528:DC%2BD28Xht1Cisr3L (Pubitemid 44737964)
36. H Kobayashi M Suzuki Y Tanaka Y Hirashima T Terao 2001 Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways J Biol Chem 276 2015 2022 11050091 10.1074/jbc.M007650200 1:CAS:528:DC%2BD3MXotVCnsg%3D%3D (Pubitemid 32109681)
37. T Shikimi K Hattori S Takaori 1992 Existence of a human urinary trypsin inhibitor (urinastatin)-like substance in the rat brain Jpn J Pharmacol 60 97 103 1479747 10.1254/jjp.60.97 1:CAS:528:DyaK38XmsVyqtb0%3D
38. T Shikimi T Wessel TH Joh M Takahashi H Kaneto K Hattori S Takaori 1993 Demonstration of a human urinary trypsin inhibitor (urinastatin)-like substance in the murine brain Brain Res 616 230 235 8358615 10.1016/0006-8993(93)90213-7 1:CAS:528:DyaK3sXkvFaiu74%3D (Pubitemid 23200051)
39. H Iwama S Ohmori T Tsutsumi 2000 Detectable concentrations of urinary trypsin inhibitor in cerebrospinal fluid J Neurosurg Anesthesiol 12 29 32 10636617 10.1097/00008506-200001000-00006 1:STN:280:DC%2BD3c7gtVGksA%3D%3D (Pubitemid 30040838)
40. D Monard 1988 Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth Trends Neurosci 11 541 544 2471310 10.1016/0166-2236(88)90182-8 1:CAS:528:DyaL1MXnt1ymug%3D%3D (Pubitemid 18269078)